Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes

Diabetes, Obesity and Metabolism

Volumn 17, Issue 11, 2015, Pages 1100-1103

  Herring, R ^a   Knight, R ^b   Shojaee Moradie, F ^c   Johnsen, S ^b   Umpleby, A M ^c   Jackson, N ^c   Jones, R ^c   Dijk, D J ^b,d   Russell Jones, D L ^a,c  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Glucose metabolism; Insulin detemir; Lipid metabolism; Type 1 diabetes; Weight

Indexed keywords

GLUCOSE; GLYCEROL; GLYCOSYLATED HEMOGLOBIN; INSULIN DETEMIR; ISOPHANE INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ALPHA RHYTHM; ALTERNATING CURRENT; BODY MASS; BRAIN FUNCTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIRECT CURRENT; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEROL BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; LIPOLYSIS; MALE; THETA RHYTHM; BLOOD; BRAIN; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; INSULIN INFUSION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

ADULT; BLOOD GLUCOSE; BRAIN; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; ELECTROENCEPHALOGRAPHY; FEMALE; GLYCEROL; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN DETEMIR; INSULIN INFUSION SYSTEMS; INSULIN, ISOPHANE; LIPOLYSIS; MALE; WEIGHT GAIN;

EID: 84944592167     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12553     Document Type: Letter

References (12)

1. Zachariah S, Sheldon B, Shojaee-Moradie F etal. Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes. Diabetes Care 2011; 34: 1487-1491.
2. Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004; 47: 622-629.
3. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes: causes, effects and coping strategies. Diabetes Obes Metab 2007; 9: 799-812.
4. Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006; 28: 1569-1581.
5. Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci 1990; 52: 29-37.
6. Shojaee Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM. Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrom 1996; 31: 961-966.
7. Flakoll PJ, Zheng M, Vaughan S, Borel MJ. Determination of stable isotopic enrichment and concentration of glycerol in plasma via gas chromatography-mass spectrometry for the estimation of lipolysis in vivo. J Chromatogr B Biomed Sci Appl 2000; 744: 47-54.
8. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956; 187: 15-24.
9. Hennige AM, Sartorius T, Tschritter O etal. Tissue selectivity of insulin detemir action in vivo. Diabetologia 2006; 49: 1274-1282.
10. Rossetti P, Porcellati F, Ricci NB etal. Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans. Diabetes 2008; 57: 746-756.
11. Hallschmid M, Jauch-Chara K, Korn O etal. Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes 2010; 59: 1101-1107.
12. Berthoud H-R. The vagus nerve, food intake and obesity. Regul Pept 2008; 149: 15-25.